These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11978505)

  • 1. Extended interval aminoglycoside dosing: from concept to clinic.
    Maglio D; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2002 Apr; 19(4):341-8. PubMed ID: 11978505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National survey of extended-interval aminoglycoside dosing.
    Chuck SK; Raber SR; Rodvold KA; Areff D
    Clin Infect Dis; 2000 Mar; 30(3):433-9. PubMed ID: 10722424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    J Antimicrob Chemother; 1997 Jun; 39(6):677-86. PubMed ID: 9222035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients.
    Mueller EW; Boucher BA
    Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily dosing of aminoglycoside antibiotics.
    Fisman DN; Kaye KM
    Infect Dis Clin North Am; 2000 Jun; 14(2):475-87. PubMed ID: 10829267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacodynamics of aminoglycosides.
    Lacy MK; Nicolau DP; Nightingale CH; Quintiliani R
    Clin Infect Dis; 1998 Jul; 27(1):23-7. PubMed ID: 9675444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-interval dosing of aminoglycosides.
    Blam ME; Hammer GS
    Mt Sinai J Med; 1997 Nov; 64(6):386-91. PubMed ID: 9364833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis.
    Hatala R; Dinh T; Cook DJ
    Ann Intern Med; 1996 Apr; 124(8):717-25. PubMed ID: 8633831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of aminoglycosides in the intensive care unit.
    Radigan EA; Gilchrist NA; Miller MA
    J Intensive Care Med; 2010; 25(6):327-42. PubMed ID: 20837630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of aminoglycosides once-a-day: experimental and clinical data.
    Tulkens PM
    Scand J Infect Dis Suppl; 1990; 74():249-57. PubMed ID: 2097713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.
    Bailey TC; Little JR; Littenberg B; Reichley RM; Dunagan WC
    Clin Infect Dis; 1997 May; 24(5):786-95. PubMed ID: 9142771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.
    Nestaas E; Bangstad HJ; Sandvik L; Wathne KO
    Arch Dis Child Fetal Neonatal Ed; 2005 Jul; 90(4):F294-300. PubMed ID: 15857879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single daily dosing of aminoglycosides.
    Preston SL; Briceland LL
    Pharmacotherapy; 1995; 15(3):297-316. PubMed ID: 7667165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
    Croes S; Koop AH; van Gils SA; Neef C
    Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing strategies in aminoglycoside dosing; the result of research on antimicrobial pharmacodynamics.
    Zhanel GG
    Zentralbl Bakteriol; 1993 Nov; 279(4):447-9. PubMed ID: 8305801
    [No Abstract]   [Full Text] [Related]  

  • 19. Some international approaches to aminoglycoside monitoring in the extended dosing interval era.
    Morris RG; Sallustio BC; Vinks AA; LeGatt DF; Verjee ZH; El Desoky E
    Ther Drug Monit; 1999 Aug; 21(4):379-88. PubMed ID: 10442690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglycoside dosing in diabetes.
    Axworthy S; Gardner D
    J Clin Pharm Ther; 2000 Apr; 25(2):81-4. PubMed ID: 10849185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.